NCT06034093 (RAIMUS) is a NA clinical trial of Real-time AI-assisted muscle ultrasound in Tetanus, sponsored by Oxford University Clinical Research Unit, Vietnam.

Who is sponsoring NCT06034093?

NCT06034093 is sponsored by Oxford University Clinical Research Unit, Vietnam.

What drugs are being tested in NCT06034093?

Interventions in NCT06034093: Real-time AI-assisted muscle ultrasound.

Is NCT06034093 still recruiting?

NCT06034093 is currently completed. Last updated 20 March 2024.

Last reviewed 2024-03-20 · How we verify

NCT06034093: RAIMUS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Real-time Artificial Intelligent (AI)-Assisted Muscle Ultrasound for Monitoring Muscle Mass Reduction in ICU Patients

Completed NA Last updated 20 March 2024

What this trial tests

NA trial testing Real-time AI-assisted muscle ultrasound in Tetanus in 254 participants. Completed in 31 October 2023.

Timeline

1 June 2020

Primary endpoint
10 August 2023

31 October 2023

Quick facts

Lead sponsor	Oxford University Clinical Research Unit, Vietnam
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	254
Start date	1 June 2020
Primary completion	10 August 2023
Estimated completion	31 October 2023
Sites	1 location across Vietnam

Drugs / interventions tested

Real-time AI-assisted muscle ultrasound

Conditions studied

Tetanus — all drugs for Tetanus →

Sponsor

Oxford University Clinical Research Unit, Vietnam

Who can join

16 and older, any sex, with Tetanus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the feasibility of using a real-time artificial intelligent (AI)-assisted tool for Rectus Femoris cross sectional area measurement from muscle ultrasound to improve reliability, reduce inter- and intra-observer variability and reduce operator time spent on ultrasound examination

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Clinical evaluation of AI-assisted muscle ultrasound for monitoring muscle wasting in ICU patients.
Nhat PTH, Van Hao N, Yen LM, Anh NH, et al · · 2024 · cited 10× · PMID 38926427 · DOI 10.1038/s41598-024-64564-w
Clinical evaluation of AI-assisted muscle ultrasound for monitoring muscle wasting in ICU patients
Nhat PTH, Van HN, Lam MY, Nguyen HA, et al · · 2023 · DOI 10.21203/rs.3.rs-3456993/v1

Verify or expand the search:

Other recruiting trials for Tetanus

Currently open trials in the same condition.

NCT07358910 — Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective · recruiting
NCT07107932 — A Registry： Siltartoxatug Injection for Tetanus Prophylaxis Following Injury · recruiting
NCT06708286 — A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) · Phase 2, PHASE3 · active not recruiting
NCT06635798 — A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR20 · Phase 3 · recruiting
NCT06184542 — Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine · Phase 1 · recruiting

Other Oxford University Clinical Research Unit, Vietnam trials

Trials by the same sponsor.

NCT07543458 — Therapeutics for Moderate and Severe Dengue · Phase 3 · not yet recruiting
NCT06551844 — Adaptive Dengue Antiviral Platform Trial · Phase 2 · not yet recruiting
NCT05909384 — Management of Sepsis in Resource Limited Settings Using a Delphi Method. · completed
NCT05611710 — Anakinra in Dengue With Hyperinflammation ( AnaDen ) · Phase 2 · active not recruiting
NCT05083130 — Awake Prone Positioning in Moderate to Severe COVID-19 · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06034093 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oxford University Clinical Research Unit, Vietnam
Last refreshed: 20 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06034093.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing